medlr news Strides Pharma Earns Spot in S&P Global Sustainability Yearbook 2025 Strides Pharma secures a spot in the S&P Global Sustainability Yearbook 2025, ranking among the top 10% globally for its strong ESG performance.
News Strides Pharma Sells Singapore Manufacturing Site for $15 Million Strides Pharma Science to sell its Singapore manufacturing facility for $15 million to Rxilient Biohub, using proceeds for debt reduction and cost-saving measures, expected to be EPS accretive.
